Navigating the intricate landscape of legal acquisition for controlled substances, specifically Schedule I drugs, represents a particularly unique area for approved Canadian institutions—typically research facilities—and demands meticulous adherence to rigorous regulations. The process goes far beyond standard provider selection, encompassing d… Read More